bumetanide (Q275926)

bumetanide (English)

3 October 2016

C₁₇H₂₀N₂O₅S

1 reference

bumetanide (English)

19 November 2016

CCCCNC1=C(C(=CC(=C1)C(=O)O)S(=O)(=O)N)OC2=CC=CC=C2

1 reference

https://www.whocc.no/atc_ddd_index/?code=C03CA02

bumetanide (English)

19 November 2016

1 milligram

route of administration

oral administration

1 reference

reference URL

1 milligram

route of administration

parenteral route of administration

1 reference

reference URL

https://www.whocc.no/atc_ddd_index/?code=C03CA02

World Health Organisation international non-proprietary name

bumetanide (English)

1 reference

bumetanide (English)

medical condition treated

3 October 2016

1 reference

13 December 2016

congestive heart failure

2 references

13 December 2016

Drug Indications Extracted from FAERS

2 October 2018

1 reference

13 December 2016

1 reference

chronic renal insufficiency

13 December 2016

1 reference

13 December 2016

1 reference

13 December 2016

arterial hypertension

1 reference

13 December 2016

1 reference

significant drug interaction

13 December 2016

desmopressin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

dronedarone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tobramycin

ototoxicity

1 reference

A reference set of clinically relevant adverse drug-drug interactions

amikacin

ototoxicity

1 reference

A reference set of clinically relevant adverse drug-drug interactions

ototoxicity

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

arsenic trioxide

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

lithium

1 reference

A reference set of clinically relevant adverse drug-drug interactions

nabumetone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

naproxen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

celecoxib

1 reference

A reference set of clinically relevant adverse drug-drug interactions

Diclofenac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

piroxicam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

meloxicam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-fenoprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(+-)-flurbiprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

ibuprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

indomethacin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-ketoprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-etodolac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

sulindac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

parecoxib

1 reference

A reference set of clinically relevant adverse drug-drug interactions

aceclofenac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tenoxicam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

lisinopril dihydrate

1 reference

A reference set of clinically relevant adverse drug-drug interactions

quinapril

1 reference

A reference set of clinically relevant adverse drug-drug interactions

ramipril

1 reference

A reference set of clinically relevant adverse drug-drug interactions

captopril

1 reference

A reference set of clinically relevant adverse drug-drug interactions

enalapril

1 reference

A reference set of clinically relevant adverse drug-drug interactions

trandolapril

1 reference

A reference set of clinically relevant adverse drug-drug interactions

fosinopril

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

perindopril

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tobramycin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

amikacin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

torsades de pointes

1 reference

A reference set of clinically relevant adverse drug-drug interactions

long QT syndrome

1 reference

A reference set of clinically relevant adverse drug-drug interactions

pulseless electrical activity

1 reference

A reference set of clinically relevant adverse drug-drug interactions

cardiotoxicity

1 reference

A reference set of clinically relevant adverse drug-drug interactions

torsades de pointes

1 reference

A reference set of clinically relevant adverse drug-drug interactions

long QT syndrome

1 reference

A reference set of clinically relevant adverse drug-drug interactions

pulseless electrical activity

1 reference

A reference set of clinically relevant adverse drug-drug interactions

cardiotoxicity

1 reference

A reference set of clinically relevant adverse drug-drug interactions

nabumetone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

naproxen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

celecoxib

1 reference

A reference set of clinically relevant adverse drug-drug interactions

Diclofenac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

piroxicam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

meloxicam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-fenoprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(+-)-flurbiprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

ibuprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

indomethacin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-ketoprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-etodolac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

sulindac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

parecoxib

1 reference

A reference set of clinically relevant adverse drug-drug interactions

aceclofenac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tenoxicam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

arsenic trioxide

torsades de pointes

1 reference

A reference set of clinically relevant adverse drug-drug interactions

arsenic trioxide

long QT syndrome

1 reference

A reference set of clinically relevant adverse drug-drug interactions

dronedarone

hypomagnesemia

1 reference

A reference set of clinically relevant adverse drug-drug interactions

lisinopril dihydrate

1 reference

A reference set of clinically relevant adverse drug-drug interactions

quinapril

1 reference

A reference set of clinically relevant adverse drug-drug interactions

ramipril

1 reference

A reference set of clinically relevant adverse drug-drug interactions

captopril

1 reference

A reference set of clinically relevant adverse drug-drug interactions

enalapril

1 reference

A reference set of clinically relevant adverse drug-drug interactions

trandolapril

1 reference

A reference set of clinically relevant adverse drug-drug interactions

fosinopril

1 reference

A reference set of clinically relevant adverse drug-drug interactions

perindopril

1 reference

A reference set of clinically relevant adverse drug-drug interactions

digoxin

heart arrhythmia

1 reference

A reference set of clinically relevant adverse drug-drug interactions

digoxin

nausea

1 reference

A reference set of clinically relevant adverse drug-drug interactions

digoxin

vomiting

1 reference

A reference set of clinically relevant adverse drug-drug interactions

lightheadedness

1 reference

A reference set of clinically relevant adverse drug-drug interactions

vertigo

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tinnitus

1 reference

A reference set of clinically relevant adverse drug-drug interactions

deafness

1 reference

A reference set of clinically relevant adverse drug-drug interactions

physically interacts with

Solute carrier family 12 member 2

enzyme inhibitor

1 reference

G protein-coupled receptor 35

17 August 2016

enzyme inhibitor

1 reference

Solute carrier family 12 member 1

17 August 2016

enzyme inhibitor

1 reference

https://nctr-crs.fda.gov/fdalabel/ui/spl-summaries/criteria/343802

17 August 2016

legal status (medicine)

boxed warning

1 reference

reference URL

Australian pregnancy category B3

FDA-sourced list of all drugs with black box warnings (Use Download Full Results and View Query links. (English)

pregnancy category

1 reference

imported from Wikimedia project

English Wikipedia

US pregnancy category C

1 reference

imported from Wikimedia project

1 reference

https://www.pfizer.com/products/product-list

sodium potassium chloride symporter inhibitors

1 reference

InChI=1S/C17H20N2O5S/c1-2-3-9-19-14-10-12(17(20)21)11-15(25(18,22)23)16(14)24-13-7-5-4-6-8-13/h4-8,10-11,19H,2-3,9H2,1H3,(H,20,21)(H2,18,22,23)

Medical Subject Headings

15 March 2018

1 reference

Medical Subject Headings

15 March 2018

2935.90.95

0 references

Commons category

Bumetanide

0 references

Identifiers

InChI

1 reference

bumetanide (English)

19 November 2016

2 references

bumetanide (English)

19 November 2016

ChEBI release 2020-09-01

CAS Registry Number

28395-03-1

2 references

bumetanide (English)

19 November 2016

https://commonchemistry.cas.org/detail?cas_rn=28395-03-1

9 April 2021

1 reference

Bumetanide (English)

19 November 2016

2 references

bumetanide (English)

19 November 2016

Reaxys registry number

2185351

1 reference

bumetanide (English)

3 October 2016

mapping relation type

2 references

BUMETANIDE (English)

19 November 2016

International Chemical Identifier

InChI

InChI=1S/C17H20N2O5S/c1-2-3-9-19-14-10-12(17(20)21)11-15(25(18,22)23)16(14)24-13-7-5-4-6-8-13/h4-8,10-11,19H,2-3,9H2,1H3,(H,20,21)(H2,18,22,23)

1 reference

BUMETANIDE (English)

19 November 2016

2 references

inferred from InChIKey

MSBNK-Univ_Connecticut-CO000086

1 reference

MassBank accession ID

MSBNK-Keio_Univ-KO009094

0 references

MSBNK-Keio_Univ-KO009095

0 references

MSBNK-Keio_Univ-KO009096

0 references

MSBNK-Keio_Univ-KO009097

0 references

MSBNK-Keio_Univ-KO009098

0 references

MSBNK-Keio_Univ-KO009099

0 references

0 references

MSBNK-Univ_Connecticut-CO000087

0 references

MSBNK-Univ_Connecticut-CO000088

0 references

MSBNK-Univ_Connecticut-CO000089

0 references

MSBNK-Univ_Connecticut-CO000090

0 references

MSBNK-Keio_Univ-KO000376

0 references

MSBNK-Keio_Univ-KO000377

0 references

MSBNK-Keio_Univ-KO000378

0 references

MSBNK-Keio_Univ-KO000379

0 references

MSBNK-Keio_Univ-KO000380

0 references

MSBNK-Keio_Univ-KO002512

0 references

MSBNK-Keio_Univ-KO002513

0 references

MSBNK-Keio_Univ-KO002514

0 references

MSBNK-Keio_Univ-KO002515

0 references

MSBNK-Keio_Univ-KO002516

0 references

MSBNK-Waters-WA001773

0 references

MSBNK-Waters-WA001774

0 references

MSBNK-Waters-WA001775

0 references

MSBNK-Waters-WA001776

0 references

MSBNK-Waters-WA001777

0 references

MSBNK-Waters-WA001778

0 references

SPLASH

splash10-03di-0119000000-4abf1963718d72f73f59

0 references

splash10-001i-9351000000-b43658e112020008b9f9

0 references

splash10-001i-9100000000-4d303174266311856c28

0 references

splash10-001i-9000000000-2d120289f52c86515bea

0 references

splash10-014i-0009000000-97827d479a3470c40d42

0 references

splash10-015c-0396000000-5edaaa0fcc7cd3681c24

0 references

splash10-000x-0980000000-0b360ca9bf4e58649db7

0 references

splash10-053s-0910000000-c5fc710abfdf5947bc62

0 references

splash10-0a4j-0900000000-368c9661bc6dfd8a8d83

0 references

splash10-000x-0291000000-134f42a8645c2f1b9bc5

0 references

splash10-0006-0291000000-84c04457e0b4a5ac43df

0 references

splash10-0006-0290000000-fb618675460e49256516

0 references

splash10-001i-0920000000-2b2887d0e4aaddc6e896

0 references

splash10-0a4l-0903000000-f314642a3021df8f2231

0 references

splash10-0k92-0980000000-d4f8616f84060bf83ba0

0 references

splash10-014i-0009000000-e4d18d4c63310d0528db

0 references

splash10-000x-0390000000-abfea32acc207ff88b1f

0 references

splash10-053r-0930000000-cc33040126bfe7cb08fa

0 references

splash10-0a5a-0910000000-42b9627a1135073b6ce1

0 references

splash10-0ars-0900000000-d22f5ff182cd71ced792

0 references

splash10-00lu-1694000000-dbf4d76ea1a12ee57935

0 references

DSSTox substance ID

DTXSID5022699

2 references

Mapping file of InChIStrings, InChIKeys and DTXSIDs for the EPA CompTox Dashboard

DSSTOX compound identifier

0 references

0 references

1 reference

bumetanide (English)

ECHA Substance Infocard ID

19 November 2016

100.044.534

1 reference

ECHA Substance Infocard database

ECHA Substance Infocard ID

27 December 2018

Bumetanide (English)

CAS no.: 28395-03-1 (English)

1 reference

Bumetanide (English)

publication date

17 November 2015

1 reference

D02.241.223.100.050.300.200

bumetanide (English)

19 November 2016

Bumetanide

0 references

0 references

0 references

0 references

D02.455.426.559.389.127.020.452.500

0 references

0 references

1 reference

bumetanide (English)

19 November 2016

1 reference

Human Metabolome Database ID

HMDB0015024

2 references

based on heuristic

inferred from InChIKey

2 references

bumetanide (English)

19 November 2016

MedlinePlus drug identifier

0 references

1 reference

bumetanide (English)

19 November 2016

0 references

1 reference

1 reference

Immune Epitope Database and Analysis Resource

bumetanide (English)

3 October 2016

1 reference

1 March 2022

1 reference

28 October 2013

Microsoft Academic ID

0 references

1 reference

26 January 2022

https://docs.openalex.org/download-snapshot/snapshot-data-format

ScienceDirect topic ID

agricultural-and-biological-sciences/bumetanide

0 references

UK Parliament thesaurus ID

521512

subject named as

Bumetanide

0 references

UMLS CUI

C0006376

1 reference